Owlet (OWLT) Total Current Liabilities (2020 - 2026)
Owlet's (OWLT) quarterly Total Current Liabilities came in at $48.1 million in Q1 2026, up 18.3% year-on-year from $40.7 million in Q1 2025, and up 8.81% on a QoQ basis from $44.2 million in Q4 2025.
Owlet (OWLT) Total Current Liabilities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Total Current Liabilities data on file, last reported at $48.1 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 18.3% year-over-year to $48.1 million in Q1 2026; TTM through Mar 2026 was $48.1 million, a 18.3% increase from a year earlier, with the FY2025 full-year figure at $44.2 million, up 21.45% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $48.1 million, up from $44.2 million in the prior quarter.
- Over the last five years, Total Current Liabilities for OWLT reached as high as $72.9 million in Q2 2022 and fell as low as $35.7 million in Q3 2024.
- Historically, Total Current Liabilities has averaged $51.2 million across 5 years, with a median of $48.1 million in 2026.
- Across the five-year window, Total Current Liabilities surged 1970.73% in 2022 and slumped 43.02% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $66.6 million in 2022, then tumbled by 32.3% to $45.1 million in 2023, then fell by 19.21% to $36.4 million in 2024, then climbed by 21.45% to $44.2 million in 2025, then rose by 8.81% to $48.1 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $48.1 million in Q1 2026, $44.2 million in Q4 2025, and $62.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn | 48.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.14 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Sep 30, 2025 | 62.94 Mn |
| Jun 30, 2025 | 52.80 Mn |
| Mar 31, 2025 | 40.70 Mn |
| Dec 31, 2024 | 36.43 Mn |
| Sep 30, 2024 | 35.69 Mn |
| Jun 30, 2024 | 42.15 Mn |
| Mar 31, 2024 | 39.46 Mn |
| Dec 31, 2023 | 45.09 Mn |
| Sep 30, 2023 | 41.10 Mn |
| Jun 30, 2023 | 48.38 Mn |
| Mar 31, 2023 | 50.72 Mn |
| Dec 31, 2022 | 66.60 Mn |
| Sep 30, 2022 | 72.13 Mn |
| Jun 30, 2022 | 72.86 Mn |
| Mar 31, 2022 | 71.57 Mn |
| Dec 31, 2021 | 69.09 Mn |
| Sep 30, 2021 | 56.32 Mn |
| Jun 30, 2021 | 4.77 Mn |